Generics 47

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Doxorubicin manufacturers

47 products found

Filters

47 products found

doxorubicin

Vials, lyophilized injection 10mg, 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Germany , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

doxorubicin

Solution for injection 10mg/5ml, 50mg/25ml, 100mg/50ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

doxorubicin

Injection 2 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

doxorubicin

Solution for injection 2mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Germany
Available for
Licensing with supply, Distribution only
Manufacturer #16717
They've been serving and assisting customers in the healthcare business in Regulatory Affairs and Pharmacovigilance for over 30 years. This sphere of action covers many countries around the world. They look after their local and European consumers and the supply chain by providing high-quality products for internationalization strategies.

Manufacturer usually replies in 14 days

doxorubicin

Solution for infusion 10mg/5ml, 20mm/10ml, 50mg/25ml , 100mg/50ml, 200mg/100ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #9300

Manufacturer usually replies in 3 days

doxorubicin

Solution for infusion 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

doxorubicin

Concentrate for solution for infusion 10 mg/5 ml, 50 mg/25 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

doxorubicin

Injection 10 mg , 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

doxorubicin

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20530
With the rapid improvement of pharmaceutical technology and the approaching aging society, they focus on the development of innovative healthcare technology for Acute and Critical Care and Anti-aging and Preventive Medicine. The company has passed US FDA, Japan PMDA, and PIC/S GMP inspections through specific approaches to total quality management.

Manufacturer usually replies in 2 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783

Manufacturer usually replies in 2 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

doxorubicin

Solution for injection 10mg, 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #16493
It is a European company having its headquarters in the same continent. The company works in the industry of Drugs and Druggists' Sundries Merchant Wholesalers. According to the company's most recent financial report, net sales revenue climbed by more than 43.44 percent in 2020. The overall assets of the company increased by more than 59.69 percent.

Manufacturer usually replies in 3 days

doxorubicin

Solution for injection 10mg, 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #15976

Manufacturer usually replies in 3 days

doxorubicin

Solution for injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

doxorubicin

Vials, injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #15119
Company specializing in the importation and registration of pharmaceuticals and medical devices, having extensive knowledge and experience in both the domestic and foreign markets, particularly in Latin American countries. They supply high-quality pharmaceutical products to internal and external clients to efficiently meet market needs and have a positive impact on community health and well-being.

Manufacturer usually replies in 3 days

doxorubicin

Vials, injection 10mg, 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Unavailable markets
Costa Rica
Manufacturer #678
It is situated in the southern part of South America. It is committed to excellence and continuous improvement. They have a production plant for the manufacturing of high value-added products like the treatment of HIV-AIDS and neurodegenerative and cardiovascular diseases.

Manufacturer usually replies in 3 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

doxorubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

Want to view all 47 products? Create your free account today!

Doxorubicin Manufacturers

Doxorubicin is a cytotoxic and anthracycline chemotherapy drug belongs to a class of drugs called Anthracyclines. It is an antineoplastic antibiotic obtained from Streptomyces peucetius. Doxorubicin is used alone or in combination with other medications to treat several different types of cancers like, cancers of the thyroid, stomach, small cell lung cancer, liver, squamous cell cancer of head, neck, ovary, breast and prostate. This medication is advised as a prescription product and generic prescription product and before using this medication, the risk of taking the drug must be weighed against the benefits it provides. Doxorubicin should be given only under medical supervision with experience in the use of chemotherapy medications. Manufacturers of Doxorubicin market these drugs under the Brand name of Caelyx, Adriamycin, Doxil. This drug is available in an injectable dosage form (powder for solution, suspension) in 2 mg/mL, 10 mg, 20 mg/1, 50 mg/1, 75 mg, 100 mg and 150 mg/1 dosage strengths. These injections are supplied in polypropylene vials in a single vial pack for single dose use and for multiple dose use. This medication is administered through an intravenous route and is usually given once every 21 to 28 days and the duration of the treatment depends on the patient’s response and the type of cancer. The recommended dose of doxorubicin in patients with adjuvant breast cancer is 60 mg/m2 administered as I.V bolus in combination with cyclophosphamide on day 1 of each 21-day treatment cycle for a total of 4 cycles. In patients with ovarian cancer, the initial recommended dose is 50 mg/m2 administered at a rate of 1 mg/min to minimize the risk of infusion reactions, if no infusion related reactions are found, the rate of infusion can be increased to complete administration for over one hour once every 21 day. Doxorubicin vials are stored at 2° C to 8° C (36° F - 46° F) with protection from light.

How does Doxorubicin work?

Doxorubicin is an anthracycline antibiotic which works by slowing or stopping the growth of cancer cells. Doxorubicin has both antimitotic and cytotoxic activity. This drug forms complexes with DNA by intercalation between base pairs and this intercalation inhibits nucleotide replication and action of DNA and RNA polymerases which results in inhibition of topoisomerase II activity (replication and transcription) by stabilizing the DNA-topoisomerase complex. The intercalation of doxorubicin with topoisomerase II to form DNA complex is the most important mechanism of doxorubicin cytocidal activity.

The Cost of Doxorubicin

An online search for the wholesale price for sale of Doxorubicin for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The wholesale price of doxorubicin 2 mg/ml intravenous solution comes at $ 17.06 for a supply of 5 milliliters with per unit cost available at $ 3.41 The cost for doxorubicin intravenous solution is around $ 26.30 for a supply of 10 milliliters with per unit cost available for as low as $ 2.63, while for 25 milliliters it costs approximately $ 29.12 The cost for doxorubicin intravenous solution is around $ 64 for a supply of 100 milliliters with per unit cost available for as low as $ 0.64

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Doxorubicin distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Doxorubicin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Doxorubicin. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Doxorubicin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Doxorubicin suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Doxorubicin Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.